Immediate Impact
56 standout
Citing Papers
New Insights into Endothelial Dysfunction in Cardiometabolic Diseases: Potential Mechanisms and Clinical Implications
2024 Standout
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
Works of Koji Imoto being referenced
The Efficacy of Tofogliflozin on Metabolic Dysfunction-Associated Fatty Liver Disease
2022
Longitudinal Structural Determinants of Atherosclerotic Plaque Vulnerability
2005
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Koji Imoto | 60 | 198 | 23 | 103 | 97 | 31 | 421 | |
| Hyon Joo Kwag | 120 | 164 | 1 | 96 | 64 | 25 | 465 | |
| Donald Kim | 29 | 218 | 2 | 65 | 54 | 30 | 400 | |
| Nouredin Messaoudi | 58 | 149 | 2 | 62 | 28 | 42 | 476 | |
| A. Rabøl | 70 | 82 | 3 | 100 | 68 | 21 | 402 | |
| Gelin Le | 58 | 146 | 4 | 164 | 25 | 47 | 474 | |
| Hong Pil Hwang | 114 | 159 | 6 | 57 | 59 | 51 | 458 | |
| Yi Li | 29 | 156 | 4 | 149 | 122 | 46 | 436 | |
| David Marx | 51 | 99 | 5 | 38 | 73 | 28 | 491 | |
| Raquel Marzoa‐Rivas | 62 | 238 | 2 | 37 | 34 | 30 | 467 | |
| Jan Willem Haveman | 70 | 255 | 4 | 147 | 23 | 36 | 505 |
All Works
Login with ORCID to disown or claim papers
Loading papers...